Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy
- PMID: 36112968
- DOI: 10.1182/blood.2022016963
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy
Erratum in
-
Wei AH, Panayiotidis P, Montesinos P, et al. Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Blood. 2022;140(25):2754-2756.Blood. 2023 Nov 23;142(21):1846-1847. doi: 10.1182/blood.2023022753. Blood. 2023. PMID: 37995101 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

